Chronic Kidney Disease-Mineral and Bone Disorder Clinical Trial
Official title:
Relationship Between Serum 1,25-dihydroxy Vitamin D and Markers of Bone Metabolism in Renal Dysfunction Patients
This cross-sectional study was conducted, including those subjects tested for 1,25(OH)2D during Jan 2015-Dec 2021. Estimated glomerular filtration rate (eGFR) was calculated and subjects were classified into chronic kidney disease (CKD) stages. Associations between biochemical marker, calcium, phosphorus, magnesium, alkaline phosphatase, 1,25(OH)2D and CKD stages was determined.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04564924 -
To Investigate the Bone and Muscle Abnormalities in Patients With Chronic Kidney Disease With MRI
|
||
Recruiting |
NCT04714918 -
Chinese CKD-MBD Prevalence Survey (CRISS-MBD)
|
||
Recruiting |
NCT06288451 -
DePTH: De-emphasize PTH
|
Phase 2 | |
Completed |
NCT04750460 -
Injection of Teriparatide to Prevent Hypocalcemia After Parathyroidectomy in Dialysis Patients (TeriCa).
|
Phase 3 | |
Recruiting |
NCT05439980 -
Improving Phosphate Control in Children With CKD
|
||
Recruiting |
NCT05096195 -
PRevEnting FracturEs in REnal Disease 1
|
Phase 4 | |
Recruiting |
NCT05242055 -
Integrated Diagnosis and Treatment of CKD on Outcomes
|
||
Recruiting |
NCT04522622 -
Treatment of Adynamic Bone Disorder With Parathyroid Hormone in Chronic Kidney Disease
|
Phase 4 | |
Recruiting |
NCT05720273 -
Neutrophil Gelatinase-associated Lipocalin VS Vascular Calcification in Maintenance Hemodialysis Patients
|
Phase 4 |